Cite
Discovery of HSD-621 as a Potential Agent for the Treatment of Type 2 Diabetes
MLA
Tarek S. Mansour, et al. Discovery of HSD-621 as a Potential Agent for the Treatment of Type 2 Diabetes. Nov. 2012. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....ac55ea3454d8d6acc241eb07df394729&authtype=sso&custid=ns315887.
APA
Tarek S. Mansour, Mylene Perreault, Joel Bard, Eva Chenail, Xianbin Tian, James F. Tobin, Xiangping Li, Jason Shaoyun Xiang, Zhao-Kui Wan, Xin Xu, Manus Ipek, Darrell Panza, Kristine Svenson, Huan-Qiu Li, Eddine Saiah, Ariful Qadri, Vipin Suri, Mengmeng Wang, Christian E. Johnson, & Seung Hahm. (2012). Discovery of HSD-621 as a Potential Agent for the Treatment of Type 2 Diabetes.
Chicago
Tarek S. Mansour, Mylene Perreault, Joel Bard, Eva Chenail, Xianbin Tian, James F. Tobin, Xiangping Li, et al. 2012. “Discovery of HSD-621 as a Potential Agent for the Treatment of Type 2 Diabetes,” November. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....ac55ea3454d8d6acc241eb07df394729&authtype=sso&custid=ns315887.